UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

May 13, 2016

Date of Report (Date of earliest event reported)

inVentiv Health, Inc.

(Exact name of registrant as specified in its charter)


Delaware	000-30318	52-2181734
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1 Van De Graaff Drive
Burlington, Massachusetts		01803
(Address of principal executive offices)		(Zip Code)

(800) 416-0555

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

As previously disclosed on a Current Report on Form 8-K filed with the Securities Exchange Commission on May 4, 2016, inVentiv Health, Inc. (the “Company”) will discuss the Company’s financial results for the first quarter of 2016 during a conference call at 2:00 p.m. Eastern Time on May 16, 2016. During this conference call, the Company intends to use and reference the presentation furnished herewith. A copy of the presentation is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information furnished on this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits


99.1		Investor Presentation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


INVENTIV HEALTH, INC.

By:		/s/ Jonathan E. Bicknell
		Name: Jonathan E. Bicknell
		Title: Chief Financial Officer

Date: May 13, 2016

INVENTIV HEALTH INC 8-K